Alzhiemer’s disease is one of the most debilitating and most popular form of mental decline. As per the estimates nearly 25-30 million of the people worldwide are affected by this debilitating condition. While alzhiemer’s disease is known to occur mostly in the elderly population of over 60 years of age, now days given the hectic lifestyle, faulty diets and polluted environment it can even occur in individuals as young as 40 years of age. While most alzheimer’s disease treatments only target the symptoms, Cerebrolysin is an innovative drug that is designed to target the cause for proper alzhiemer’s disease treatment.
However, since initial symptoms are very mild and of generic nature like general forgetfulness people tend to ignore these symptoms, thus making this disease remain undiagnosed for a long time. While there are innumerable studies and theories regarding the cause of this serious mental decline, the exact cause still remains unknown and obscure.
